Medical Oncology Board Review Course

Medical Oncology Board Review Course

$100

Categories: ,

Medical Oncology Board Review Course

AGENDA
Hematologic Neoplasms
Acute Leukemia and Myelodysplasia (1 Hour)
Peter Silberstein, MD
Chronic Myeloid Leukemia and Myeloproliferative Neoplasms (.75 Hour)
Peter Silberstein, MD
Chronic Lymphoproliferative Leukemias (.75 Hour)
Peter Silberstein, MD
Hodgkin Lymphoma (.25 Hour)
Peter Silberstein, MD
Multiple Myeloma and Plasma Cell Dyscrasias (.75 Hour)
Peter Silberstein, MD
Non-Hodgkin Lymphoma (1.5 Hours)
Peter Silberstein, MD
Thoracic Cancer
Non-small cell lung cancer (3.25 Hours)
Tanguy Seiwert, MD
Small Cell Lung Cancer (.25 Hour)
Tanguy Seiwert, MD
Mesothelioma and Thymus Cancer (.25 Hour)
Tanguy Seiwert, MD
Breast Cancer
Premalignant Conditions and High-Risk Factors (.25 Hour)
Lea Baer, MD
Carcinoma in Situ (.25 Hour)
Lea Baer, MD
Early-Stage Invasive Carcinoma (1.75 Hours)
Lea Baer, MD
Locally advanced and inflammatory disease (.25 Hour)
Lea Baer, MD
Locally Recurrent Disease (.25 Hour)
Lea Baer, MD
Metastatic Disease (1.5 Hours)
Lea Baer, MD
Less Common Histologies and Clinical Scenarios (.25 Hour)
Lea Baer, MD
Genitourinary Cancer
Germ Cell Tumors (.25 Hour)
Terence Friedlander, MD
Prostate Cancer (1.75 Hours)
Terence Friedlander, MD
Renal Cell Cancer (1 Hour)
Terence Friedlander, MD
Urothelial and other Genitorourinary cancers (1 Hour)
Terence Friedlander, MD
Gynecologic Cancer
Cancer of the Cervix, Vulva, and Vagina (.25 Hour)
Peter Silberstein, MD
Ovarian, Fallopian Tube, and Primary Peritoneal Cancers (1 Hour)
Peter Silberstein, MD
Other Gynecologic Malignancies (.25 Hour)
Peter Silberstein, MD
Gastrointestinal Cancer
Gastrointestinal – Colorectal Cancer (1 Hour)
Michael Morse, MD
Gastrointestinal – Esophageal and Gastric Cancer (1 Hour)
Michael Morse, MD
Gastrointestinal – Hepatocellular and Biliary Gallbladder Cancer and Neuroendocrine Tumors (1 Hour)
Michael Morse, MD
Gastrointestinal – Pancreatic and Anal Cancer (1 Hour)
Michael Morse, MD
Skin Cancer, Sarcomas, and Unknown Primary Site
Melanoma (.25 Hour)
Natalya Mar, MD
Other Skin Cancers (.25 Hour)
Natalya Mar, MD
Bone and Soft-Tissue Sarcomas (.25 Hour)
Natalya Mar, MD
Unknown Primary Site (1.25 Hours)
Natalya Mar, MD
Anticancer Therapeutics, Clinical Research Methodology, and Ethics
Principles of Allied Disciplines (.25 Hour)
Sridhar Mani, MD
Anticancer Therapeutics (3 Hours)
Sridhar Mani, MD
Clinical Research Methodology and Ethics (.25 Hour)
Sridhar Mani, MD
Supportive Care, Survivorship, and Communication
Clinical Manifestations of advanced cancer and its treatment (1.5 Hours)
Peter Silberstein, MD
Cancer Pain (.75 Hour)
Peter Silberstein, MD
Survivorship Issues (.25 Hour)
Peter Silberstein, MD
End of Life Issues (.75 Hour)
Peter Silberstein, MD
Procedure-related issues (.25 Hour)
Peter Silberstein, MD
Communication (.25 Hour)
Peter Silberstein, MD
Head, Neck, Thyroid, and Central Nervous System Malignancies
Squamous cell carcinoma of the head and neck (.25 Hour)
Tanguy Seiwert, MD
Salivary Gland Tumors (.25 Hour)
Tanguy Seiwert, MD
Thyroid Cancer (.25 Hour)
Tanguy Seiwert, MD
Nasopharyngeal Carcinoma (.25 Hour)
Tanguy Seiwert, MD
Central nervous system malignancies (.25 Hour)
Tanguy Seiwert, MD
Genetics and Tumor Biology
Cancer Biology and Genetics (.25 Hour)
Tanguy Seiwert, MD
Tumor Immunology (.25 Hour)
Tanguy Seiwert, MD
Heritable Cancer Syndromes (.25 Hour)
Tanguy Seiwert, MD
Epidemiology of cancer (.25 Hour)
Tanguy Seiwert, MD
CME ACCREDITATION

Read What Your Colleagues Are Saying About This Course

“First of all I would like to thank you for arranging this course. It was very precise and extremely full of information. It is also very applicable to our daily practice following the new standard guidelines.”

Sapna R. Patel, MD

“I completed all of the online lectures prior to this live course which greatly improved my experience with the live course compared to previous live courses. I think that the more I do the more I will retain and improve my likelihood of passing.”

Jack Saux, MD

“It’s a nice “comprehensive review” as any other CME, but I would rate it # 1 among others. In order to stand out as a “pass machine” tool you would need to saturate the content to high yield info in order to be focused on the best.”

Boris Darovsky

“Faculty was well-prepared and experts in their field. Presentations were laser (curated?) toward board-related material.”

Robert Ellis, MD, Vancouver, WA

“Excellent course. Definitely helped me getting a great score. Highly recommend it.”

Jorge Leguizamo, MD, Atlanta, GA

“Excellent course. Overall, a good review of Medical Oncology.”

Richard C. Phinney

“Well-organized, and friendly staff were helpful.”

Steve Heddinger, MD, Waukee, IA

“Excellent, very well-structured, clear, focused.”

Yelitza Ruiz, MD, San Juan, PR

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related Products